Cellular Plasticity and the Tumor Ecosystem Meeting

Quanterix is excited to connect with researchers to advance tumor biology.

Quanterix is proud to participate in the Cellular Plasticity and the Tumor Ecosystem, a premier scientific gathering designed to accelerate collaboration, spark new discoveries, and advance the future of cancer treatment. Hosted by Case Western Reserve University Case Comprehensive Cancer Center from August 5-6, this event brings together leading researchers, clinicians, and industry innovators focused on translating breakthrough science into meaningful patient impact.

Advancing tumor microenvironment research through ultrahigh-plex spatial proteomics

At this meeting, Quanterix—together with Akoya Biosciences, now part of Quanterix—will engage with researchers focused on unraveling the cellular, molecular, and spatial dynamics that drive cancer progression, metastasis, and therapeutic response. We are eager to highlight our spatial biology platforms that enable researchers to move seamlessly from ultrahigh-plex biomarker detection to high‑throughput spatial signatures, delivering deep insights into cancer biology.

Attend our lunch session

Discover how spatial proteomics is enabling researchers to map the tumor microenvironment at single-cell resolution and uncover biological insights not accessible through traditional approaches. Hear from a researcher as well as a spatial biology technical expert from Quanterix.

From Tissue to Insight: Ultrahigh-plex Spatial Proteomics with the Akoya PhenoCycler-Fusion

Ladan Gheiratmand, PhD

Senior Field Applications Scientist, Quanterix

Ladan will highlight how the Akoya PhenoCycler-Fusion enables researchers to:

• Visualize complex tissue architecture and cell-state transitions at whole-slide, single-cell resolution.
• Characterize immune-tumor interactions, therapeutic resistance mechanisms, and microenvironmental heterogeneity in situ.
• Accelerate biomarker discovery and translational research with scalable molecular barcoding and validated ready-to-use panels.
• Integrate spatial proteomics with single-cell and multiomic approaches to uncover actionable biological insights.
• Learn how researchers are using the Akoya PhenoCycler-Fusion platform to study cancer progression, metastasis, and treatment response.

Examinations of the Glioblastoma Microenvironment with the Akoya PhenoCycler-Fusion

Daniel J. Silver, PhD

Instructor, Department of Pathology, Cleveland Clinic Lerner College of Medicine

Daniel will share how ultrahigh-plex spatial proteomics is uncovering the cellular interactions and spatial biology that drive glioblastoma progression and therapeutic resistance. His research is focused on:

• Characterizing the cellular composition and spatial organization of the glioblastoma microenvironment.
• Uncovering how immune and stromal cell interactions influence tumor growth, invasion, and therapeutic response.
• Identifying spatially distinct cellular states and neighborhoods associated with disease progression and resistance.
• Leveraging ultrahigh-plex spatial proteomics to generate new biological insights from complex brain tumor tissues.
• Demonstrating how spatial biology can reveal mechanisms of glioblastoma evolution not observable through conventional tissue analysis.

Why connect with Quanterix?

Conference attendees are invited to connect with us during the conference to explore how spatial biology solutions help researchers understand cancer in situ. Our spatial technologies reveal how cells, phenotypes, and pathways interact within complex tumor ecosystems.

Expertise on site

Ladan Gheiratmand, PhD

Senior Field Applications Scientist, Quanterix

lgheiratmand@quanterix.com

Jim Maki

Senior Business Development Manager, Quanterix

jmaki@quanterix.com

Our spatial platforms support research in:

• Tumor heterogeneity and metastatic biology, enabling visualization of distinct cell populations and functional states within intact tissue.
• Immune‑oncology and the tumor microenvironment, mapping immune–tumor interactions that influence progression and therapeutic response.
• Translational cancer research, linking spatial tissue insights with biomarker studies across discovery and development.
• Integrated study strategies, combining spatial tissue data with quantitative protein analysis from blood.

By placing molecular data into spatial context, Quanterix helps researchers generate clear, actionable insights into cancer biology.